These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32504683)

  • 1. Vaginal Estrogen-What a Urologist Should Know.
    Escobar C; Rosenblum N
    Urology; 2021 May; 151():37-43. PubMed ID: 32504683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
    Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
    Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
    Steele NM; Ledbetter CA; Bernier F
    Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urogenital atrophy: prevention and treatment.
    Willhite LA; O'Connell MB
    Pharmacotherapy; 2001 Apr; 21(4):464-80. PubMed ID: 11310520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not time to abandon use of local vaginal hormone therapies.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaginal estrogens for the treatment of dyspareunia.
    Krychman ML
    J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
    Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
    Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection and management of vaginal atrophy.
    Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
    J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial.
    Bumphenkiatikul T; Panyakhamlerd K; Chatsuwan T; Ariyasriwatana C; Suwan A; Taweepolcharoen C; Taechakraichana N
    BMC Womens Health; 2020 Aug; 20(1):173. PubMed ID: 32787848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urogenital system and the menopause.
    Calleja-Agius J; Brincat MP
    Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
    Paton DM
    Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration.
    Notelovitz M
    Maturitas; 1995 Dec; 22 Suppl():S31-3. PubMed ID: 8775774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Prevention of Recurrent UTIs With Vaginal Estrogen: Pearls for a Urological Approach to Genitourinary Syndrome of Menopause.
    Buck ES; Lukas VA; Rubin RS
    Urology; 2021 May; 151():31-36. PubMed ID: 32533967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors.
    Zuo SW; Wu H; Shen W
    Menopause; 2018 Jul; 25(7):828-836. PubMed ID: 29533365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and the lower urinary tract.
    Robinson D; Cardozo L
    Neurourol Urodyn; 2011 Jun; 30(5):754-7. PubMed ID: 21661025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.